1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1200/jco.2005.04.3273" target="_blank" rel="noreferrer noopener">http://doi.org/10.1200/jco.2005.04.3273</a>
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Pages
2028-2037
Issue
13
Volume
24
Search for Full-text
Locate full-text within NEOMED Library's e-journal collections
<p>Users with a NEOMED Library login can search for full-text journal articles at the following url: <a href="https://libraryguides.neomed.edu/home">https://libraryguides.neomed.edu/home</a></p>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five national surgical adjuvant breast and bowel project node-positive adjuvant breast cancer trials
Publisher
An entity responsible for making the resource available
Journal of Clinical Oncology
Date
A point or period of time associated with an event in the lifecycle of the resource
2006
2006-05
Subject
The topic of the resource
20-year follow-up; conservative surgery; conserving therapy; doxorubicin-cyclophosphamide; european organization; local recurrence; Oncology; radiation-therapy; randomized-trial; risk-factors; stage-i
Creator
An entity primarily responsible for making the resource
Wapnir I L; Anderson S J; Mamounas E P; Geyer C E; Jeong J H; Tan-Chiu E; Fisher B; Wolmark N
Description
An account of the resource
Purpose Locoregional failure after breast-conserving surgery is associated with increased risk of distant disease and death. The magnitude of this risk in patients receiving chemotherapy has not been adequately characterized. Patients and Methods Our study population included 2,669 women randomly assigned onto five National Surgical Adjuvant Breast and Bowel Project node-positive protocols (B-15, B-16, B-18, B-22, and B-25), who were treated with lumpectomy, whole-breast irradiation, and adjuvant systemic therapy. Cumulative incidences of ipsilateral breast tumor recurrence (IBTR) and other locoregional recurrence (oLRR) were calculated. Kaplan-Meier curves were used to estimate distant-disease-free survival (DDFS) and overall survival (OS) after IBTR or oLRR. Cox models were used to model survival using clinical and pathologic factors jointly with IBTR or oLRR as time-varying predictors. Results Four hundred twenty-four patients (15.9%) experienced locoregional failure; 259 (9.7%) experienced IBTR, and 165 (6.2%) experienced oLRR. The 10-year cumulative incidence of IBTR and oLRR was 8.7% and 6.0%, respectively. Most locoregional failures occurred within 5 years (62.2% for IBTR and 80.6% for oLRR). Age, tumor size, and estrogen receptor status were significantly associated with IBTR. Nodal status and estrogen and progesterone receptor status were significantly associated with oLRR. The 5-year DDFS rates after IBTR and oLRR were 51.4% and 18.8%, respectively. The 5-year OS rates after IBTR and oLRR were 59.9% and 24.1%, respectively. Hazard ratios for mortality associated with IBTR and oLRR were 2.58 (95% CI, 2.11 to 3.15) and 5.85 (95% CI, 4.80 to 7.13), respectively. Conclusion Node-positive breast cancer patients who developed IBTR or oLRR had significantly poorer prognoses than patients who did not experience these events.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1200/jco.2005.04.3273" target="_blank" rel="noreferrer noopener">10.1200/jco.2005.04.3273</a>
Format
The file format, physical medium, or dimensions of the resource
Journal Article
20-year follow-up
2006
Anderson S J
conservative surgery
conserving therapy
doxorubicin-cyclophosphamide
european organization
Fisher B
Geyer C E
Jeong J H
Journal Article
Journal of Clinical Oncology
local recurrence
Mamounas E P
oncology
radiation-therapy
randomized-trial
risk-factors
stage-i
Tan-Chiu E
Wapnir I L
Wolmark N